Spiess K, Sachs G, Pietschmann P, Prager R
Institute of Medical Psychology, University of Vienna, Austria.
Eur J Endocrinol. 1995 May;132(5):580-6. doi: 10.1530/eje.0.1320580.
This paper reports the results of a prospective controlled trial of a program addressing reduction of onset distress and better future adaptation in adults who were enrolled at the time of diagnosis of type I diabetes mellitus. Patients were assigned randomly to either standard intensive treatment and patient education with the distress reduction program (N = 10) or to standard intensive treatment and patient education without this program (N = 13). Prospective follow-up of patients with multiple validated measures of treatment outcome showed less anxious coping behavior, less depression and less denial at the 9-month follow-up and less denial at the 15-month follow-up in the group with the distress reduction program, but no differences in metabolic control between the two groups at any time. We conclude that our program has a positive impact on the crisis at diabetes onset; the lower denial in the treatment group may lead to improved regimen adherence in the long term.
本文报告了一项前瞻性对照试验的结果,该试验针对的是在I型糖尿病确诊时就已登记入组的成年人,旨在减轻发病时的痛苦并使其在未来更好地适应。患者被随机分为两组,一组接受标准强化治疗和患者教育,并参与减轻痛苦计划(N = 10),另一组接受标准强化治疗和患者教育,但不参与该计划(N = 13)。对患者进行多项经过验证的治疗结果测量的前瞻性随访发现,在9个月随访时,参与减轻痛苦计划的组中焦虑应对行为更少、抑郁程度更低且否认情况更少;在15个月随访时,该组否认情况也更少,但两组在任何时候的代谢控制情况均无差异。我们得出结论,我们的计划对糖尿病发病时的危机有积极影响;治疗组中较低的否认程度可能会在长期内导致更好的治疗方案依从性。